Mahmoud Mahmoudian, PhD. FRSC

Current

• Vaccines & Biologics at Merck & Co. USA

Past

• Biotechnology: Global Director R&D and Alliances & Partnerships at Rohm & Haas Biotech (Dow), USA
• Biotechnology: Global Head R&D and Strategic Alliances at Eastman Biotech, USA
• Preclinical Development & Biopharma at GlaxoSmithKline, UK

• Biotechnology: Senior Research Fellow at ICI BioProducts (Avecia, AstraZeneca), UK

see less...

1 more...

Education

• University of Pennsylvania - The Wharton School
• Imperial College London

Recommended

1 person has recommended Mahmoud

Connections

119 connections

Industry

Pharmaceuticals

Mahmoud Mahmoudian, PhD. FRSC’s Summary

Merck & Co. USA (2007 – present): Responsible for Merck's strategic sourcing and partnerships in vaccines and biologics on a global basis.

Venture Capitals USA (2006 – present): Advisor to life sciences venture funds in Philadelphia and Boston consulting on business plans, market and technology assessments, resulting in investment opportunities in several early to mid-stage biotech companies.

Established 2 biosciences business ventures, at Eastman and Rohm & Haas (2002 – 2007), via partnerships, licensing deals, and joint ventures including Genencor and Sanofi-Aventis.

Eastman Biotech USA: Set up a biotech growth initiative within 3 years of inception. Developed a BioProduct portfolio through external alliances with a potential market value of $500m.

Rohm & Haas Biotech USA: Developed a biosciences corporate strategy, closing 2 deals within 12 months, in a $2 billion market space. Initiated negotiations with 6 partners including Genzyme. In 2008 Rohm & Haas was acquired by Dow for $18 billion.

GlaxoSmithKline UK (1989 – 2002): Principal Investigator in the discovery, research and development of 6 blockbusters with combined annual sales of $15 billion, including Lamuvidine (anti-hepatitis), Epivir (anti-HIV), Abacavir (anti-HIV), Relenza (anti-flu), Zygara (anti-leukaemic) and tribactam antibiotics (infectious diseases).

Mahmoud Mahmoudian, PhD. FRSC’s Specialties:

Business Development Leader with expertise in pharmaceutical, biotechnology and biopharma alliances & partnerships, deal negotiations, due diligence, licensing, alliance management, marketing & corporate strategy, and external scientific affairs. Extensive expertise in drug discovery, preclinical development, manufacturing, operations, production of pharmaceuticals, vaccines, biologics and therapeutic proteins, with an international biotech network and consultancy background in life sciences.

Mahmoud Mahmoudian, PhD. FRSC’s Experience

• Vaccines & Biologics

  Merck & Co. USA

  (Public Company; 10,001 or more employees; MRK; Pharmaceuticals industry)

  2007 — Present (1 year)

  Strategic sourcing and partnerships in vaccines & biologics. Recipient of Merck Award of Excellence for leadership and business acumen (2008). Team Recognition Award for top performance cross divisional teamwork in biological outsourcing (2008).

• Biotechnology: Global Director R&D and Alliances & Partnerships

  Rohm & Haas Biotech (Dow), USA

  (Chemicals industry)

  2005 — 2007 (2 years)

  Established a new corporate biosciences growth initiative, directing the strategic alliances and research functions in five R&D centers globally (USA, UK, France, China, Japan), covering a diverse portfolio with $10m budget. Member of 1) corporate growth team for healthcare, 2) Technical Council and 3) Emerging Technology Board of Directors reviewing new technologies, corporate funding and strategies.

• Biotechnology: Global Head R&D and Strategic Alliances

  Eastman Biotech, USA

  (Chemicals industry)

  2002 — 2005 (3 years)

  Member of corporate Biotechnology Board of Directors. Established a new corporate biotech business venture, Eastman Biotech a unit of Eastman Chemical Company, within 3 years of inception, responsible for strategic alliances, R&D, growth and development of a BioProduct portfolio with $5m budget.

• Preclinical Development & Biopharma

  GlaxoSmithKline, UK

  (Public Company; 10,001 or more employees; GSK; Pharmaceuticals industry)

  1989 — 2002 (13 years)

  Biotech, Biopharma, Drug Discovery, Preclinical R&D:
  
  Extensive experience in 1) discovery research and preclinical drug development (emerging technologies, lead optimization, high throughput screening, combinatorial biosynthesis, drug metabolism, natural products, fermentation, enzyme & microbial technologies, biocatalysis, bioprocessing), 2) chemical development for scale up and technology transfer to global bio-manufacturing sites, and 3) key strategic alliances in several disease areas (oncology, CNS, anti-viral, infectious diseases) for production of therapeutic proteins and chiral pharmaceuticals (API).

• Biotechnology: Senior Research Fellow

  ICI BioProducts (Avecia, AstraZeneca), UK

  (Pharmaceuticals industry)

  1984 — 1989 (5 years)

  Senior Research Fellow, BioProducts.

Mahmoud Mahmoudian, PhD. FRSC’s Education

• University of Pennsylvania - The Wharton School

  Executive Strategic Marketing 2006 — 2007

• Imperial College London

  MSc, PhD, Biotechnology, 1985 — 1989

  Scholarship from ICI BioProducts (Avecia, AstraZeneca)

Additional Information

Mahmoud Mahmoudian, PhD. FRSC’s Groups:

Licensing Executive Society USA; Business Development Institute USA; Private Equity & Venture Capital Group USA; Biotechnology Industry Organization USA; Greater Philadelphia Senior Executive Group USA; Pharmaceutical Consulting Consortium Inc. USA; Industrial Research Institute USA; The Life Science Executive Exchange USA; Asia-Pacific Pharmaceutical Industry Professionals USA.

•    Greater Philadelphia Senior Executive Group
•    BIO International Convention
•    Private Equity and Venture Capital Group
•    Global Sourcing
•    Licensing Executives Society U.S.A. and Canada (LES)
•    Biotech & Pharma Professionals Network
•    Mid-Atlantic Bio
•    Japan Biotech Network
•    The Life Science Executive Exchange
•    The Global Business Development Network
•    Business Development Institute (BDI)
•    Merck and Co. Network
•    GSK Employees and Alumni Network (~2750 members)
•    Global Healthcare

Mahmoud Mahmoudian, PhD. FRSC’s Honors:

Advisory Boards:

Board member European Federation on Biotechnology, European Union (2008)

Serving on the International Editorial Advisory Board of 7 scientific journals (1999 – present)

Government advisory panels. Advisor for evaluating research proposals, allocating funding to universities and institutions throughout Britain (1995 – 2000)

FRSC. Fellow of the Royal Society of Chemistry, England (2001)
_________________________________

Mahmoud Mahmoudian, PhD, FRSC
Pennsylvania, PA, USA
mm6382@yahoo.co.uk